Skip to main content
Clinical Trials/NCT04832308
NCT04832308
Withdrawn
Not Applicable

Mobile Intervention Supervised Exercise Therapy Study 1

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Artery Disease
Sponsor
Palo Alto Veterans Institute for Research
Primary Endpoint
Number of Participants Who Complete a 12-week Exercise Therapy Program
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

This is a randomized controlled trial evaluating the impact of the mobile phone delivered SVS SET Program on utilization, functional capacity, symptoms and quality of life.

Detailed Description

This is a national randomized controlled study with approximately 10-15 sites enrolling patients with Rutherford II peripheral artery disease (PAD) in total. Patients will be randomized between the SVS SET Program and "usual care" for each site. The primary outcome will be to study the site-specific effect on utilization of exercise therapy. Secondary outcomes will be the effect on the 6-minute-walk test, passive activity and quality of life.

Registry
clinicaltrials.gov
Start Date
August 20, 2021
End Date
June 1, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Oliver Aalami

Clinical Associate Professor of Surgery

Stanford University

Eligibility Criteria

Inclusion Criteria

  • 18 years of Age
  • Rutherford Class I-II PAD (claudication)
  • Ambulatory
  • Exercise Therapy Naive (\>18 mo)
  • Primary Owner of an Android or iOS device
  • Willingness to participate (text, call, fill out surveys) via a mobile phone

Exclusion Criteria

  • Symptomatic coronary artery disease
  • Oxygen dependent COPD
  • Significant osteoarthritis limiting ambulation

Outcomes

Primary Outcomes

Number of Participants Who Complete a 12-week Exercise Therapy Program

Time Frame: 12 weeks.

Completion of a 12-week program in the treatment group will be completion of the remote SVS SET Program while the "usual care" group may have an in-person 12-week exercise therapy program.

Secondary Outcomes

  • Adherence as Measured by Completion of Scheduled Daily Walks(12 weeks.)
  • Quality of Life Survey as measured by the mini-Walking Impairment Questionnaire (mini-WIQ)(Weeks 1, 6, and 12)
  • Mobile Phone Delivered 6-Minute Walk Test(Weeks 0, 6 and 12)
  • Freedom From Intervention as Measured by Absence of Surgical Intervention at One Year(1 year.)
  • Passive Activity as Measured on Mobile Device(12 weeks.)

Similar Trials